Abstract
The fragile X syndrome (FXS), the most common cause of heritable intellectual disability, is caused by expansion of a CGG repeat located at the 5′ UTR of the FMR1 gene and subsequent epigenetic modifications of its promoter. Epigenetic modifications include both methylation of the cytosines of the CpG island in the promoter region and of the expanded CGG triplet, and posttranslational histone changes. The combination of these changes, one structural (expansion) and one epigenetic (methylation and histone modifications), results in transcriptional silencing, even though the coding region of the FMR1 gene remains intact. Here we describe the molecular methods used to study both DNA methylation and histone epigenetic modifications, namely, bisulfite sequencing and quantification of immunoprecipitated DNA after Chromatin Immunoprecipitation (ChIP).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hagerman PJ (2008) The Fragile X prevalence paradox. J Med Genet 45:498–499
Smeets HJ, Smits AP, Verheij CE et al (1995) Normal phenotype in two brothers with a full FMR1 mutation. Hum Mol Genet 4:2103–2108
Pietrobono R, Tabolacci E, Zalfa F et al (2005) Molecular dissection of the events leading to inactivation of the FMR1 gene. Hum Mol Genet 14:267–277
Tabolacci E, Moscato U, Zalfa F et al (2008) Epigenetic analysis reveals a euchromatic configuration in the FMR1 unmethylated full mutations. Eur J Hum Genet 16:1487–1498
Naumann A, Hochstein N, Weber S et al (2009) A distinct DNA- methylation boundary in the 5′- upstream sequence of the FMR1 promoter binds nuclear proteins and is lost in fragile X syndrome. Am J Hum Genet 85:606–616
Coffee B, Zhang F, Warren ST et al (1999) Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells. Nat Genet 22:98–101
Coffee B, Zhang F, Ceman S et al (2002) Histone modifications depict an aberrantly heterochromatinized FMR1 gene in fragile X syndrome. Am J Hum Genet 71:923–932
Tabolacci E, Pietrobono R, Moscato U et al (2005) Differential epigenetic modifications in the FMR1 gene of the fragile X syndrome after reactivating pharmacological treatments. Eur J Hum Genet 13:641–648
Chiurazzi P, Pomponi MG, Willemsen R et al (1998) In vitro reactivation of the FMR1 gene involved in fragile X syndrome. Hum Mol Genet 7:109–113
Chiurazzi P, Pomponi MG, Pietrobono R et al (1999) Synergistic effect of histone hyperacetylation and DNA demethylation in the reactivation of the FMR1 gene. Hum Mol Genet 8:2317–2323
Acknowledgments
The authors’ work cited in the references was supported by Telethon Onlus and by the FRAXA Foundation.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer New York
About this protocol
Cite this protocol
Tabolacci, E., Neri, G. (2013). Epigenetic Modifications of the FMR1 Gene. In: Kohwi, Y., McMurray, C. (eds) Trinucleotide Repeat Protocols. Methods in Molecular Biology, vol 1010. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-411-1_10
Download citation
DOI: https://doi.org/10.1007/978-1-62703-411-1_10
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-410-4
Online ISBN: 978-1-62703-411-1
eBook Packages: Springer Protocols